Successful certification: Hoffrichter GmbH strengthens presence on the Chinese market

Schwerin / February 9, 2024 – Hoffrichter GmbH announces the successful certification of its "Ivory pro" respiratory therapy devices. Following the "LAVI 2023" and "LAVI 30" ventilators, which were already approved in 40, the six variants of the "Ivory pro" series received Chinese approval in January 2024.

The "Ivory pro" series represents the Chinese version of Hoffrichter's international "TREND III" product line. This certification underscores the company's positioning in the Chinese market for respiratory therapy and home ventilation technologies. In addition to these products, Hoffrichter also holds certifications for "TRENDvent," "iCARAT et," "Vital," and "Ivory."

The company remains committed to offering high-quality and innovative medical technology solutions to meet the demands of the Chinese market. 95% of our high-quality medical products are exported worldwide from our site in Schwerin.